Clinical trial

Proton MR Spectroscopy and 18F-Fluorocholine PET for Breast Cancer Diagnosis

NCT01956409

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention 18F-FCH Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Magnevist Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Proton MR Spectroscopy and 18F-Fluorocholine PET for Breast Cancer Diagnosis

Design: INTERVENTIONAL · Status: UNKNOWN · Phase: PHASE4

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2012-09-01

PhasePHASE4

Conditions

Breast Cancer Diagnosisunresolved

Positron Emission Tomographyunresolved

Magnetic Resonance Imagingunresolved

Interventions

18F-FCHDRUG

MagnevistDRUG

Sponsors & collaborators

National Taiwan University Hospitallead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01956409 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.